Metastatic carcinoid tumor with severe double valve disease at diagnosis: Case report and review of literature
A 27-year-old woman with a history of anxiety presented with three months of diarrhea. On
physical examination, she had a grade 3/6 systolic heart murmur at the lower left sternal border
which increased with inspiration, a grade 2/6 decrescendo diastolic murmur at the left sternal
border, and lower extremity edema. Stool studies were negative. The abdominal ultrasound
demonstrated multiple complex liver cysts. Transthoracic echocardiogram reported tricuspid
valvular thickening with stenosis and regurgitation, severe pulmonary stenosis, and mild aortic
regurgitation with valvular thickening. 5-hydroxyindole acetic acid and chromogranin A levels
were elevated. The patient’s symptoms improved after octreotide therapy, and she underwent
tricuspid and pulmonary valve replacement.
The incidence of carcinoid tumors is 1.2 to 2.1 per 100,000 people in the general population.
Carcinoid heart disease occurs in one-half to two-thirds of patients with carcinoid syndrome
and is associated with poorer clinical outcomes. Left side cardiac involvement occurs in less
than 10% of patients. The presence of both left and right sided valvular disease in the context
of gastrointestinal carcinoid is associated with severe and poorly controlled disease. Up to
4% of these cases have metastatic disease on the valves, and 3.8% have direct myocardial
Papaxoinis G, Syrigos K, Saif MW. New concepts in the
treatment strategy of neuroendocrine tumors: The role of
biotherapy. Discov Med 2016; 21(117): 381–9.
Kunz PL. Carcinoids and neuroendocrine tumors: Building
on success. J Clin Oncol 2015; 1; 33(16):1855–63.
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares
JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans
DB. One hundred years after “carcinoid”: Epidemiology
of and prognostic factors for neuroendocrine tumors
in 35,825 cases in the United States. J Clin Oncol 2008;
Mocellin S, Nitti D. Gastrointestinal carcinoid: Epidemiological
and survival evidence from a large population-based
study (n = 25 531). Ann Oncol 2013; 24(12):3040–4.
Öberg K. Neuroendocrine gastro-enteropancreatic tumors –
from eminence based to evidence-based medicine – A Scandinavian
view. Scand J Gastroenterol 2015; 50(6): 727–39.
Kulke MH, Siu LL, Tepper JE, Fisher G, Jaffe D, Haller DG,
Benedetti JK, Bergsland EK, Hobday TJ, Van Cutsem E,
Pinkpank J, Öberg K, Cohen SJ, Posner MC, Yao JC. Future
directions in the treatment of neuroendocrine tumors: Consensus
report of the National Cancer Institute Neuroendocrine
Tumor clinical trials planning meeting. J Clin Oncol
; 29(7): 934–43.
Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic
neuroendocrine cell system and its tumors: The WHO classification.
Ann N Y Acad Sci. 1014: 13–27, 2004.
Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid
tumors. Cancer 1997;79(4): 813–29.
Melmon KL, Sjoerdsma A, Oates JA, Laster L. Treatment of
malabsorption and diarrhea of the carcinoid syndrome with
methysergide. Gastroenterol 1965; 48: 18–24.
Melmon KL. Vasoactive substances in the pathogenesis of
migraine headache, carcinoid syndrome and other diseases.
Headache 1965; 5(3): 87–8.
Engelman K, Lovenberg W, Sjoerdsma A. Inhibition of serotonin
synthesis by para-chlorophenylalanine in patients with
carcinoid syndrome. N Engl J Med 1967; 277(21): 1103–8.
Anderson AS, Krauss D, Lang R. Cardiovascular complications
of malignant carcinoid disease. Am Heart J 1977;
Bernheim AM, Conolly HM, Hobday TJ, Pellikka PA. Carcinoid
heart disease. Prog Cardiovasc Dis 2007; 49(6): 439-51.
Palaniswamy C, Frishman WH, Anorow WS. Carcinoid
heart disease. Cardiol Rev 2012; 20(4): 167–76.
Manoly I, McAnelly SL, Sriskandarajah S, McLaughlin KE.
Prognosis of patients with carcinoid disease after valvular surgery.
Interact Cardiovasc Thorac Surg 2014; 19(2): 302–5.
Edwards NC, Yuan M, Nolan O, Pawade TA, Oleofse T,
Singh H, Mehrzad H, Zia Z, Geh JI, Palmer DH, May CJ,
Ayuk J, Shah T, Rooney SJ, Steeds RP. Effect of valvular
surgery in carcinoid heart disease: An observational cohort
study. J Clin Endocrinol Metab 2016; 101(1): 183–90.
- There are currently no refbacks.